Not logged in Share Save
Androgen Receptor Pathway Inhibitor Therapy for Advanced Prostate Cancer Bastos, Diogo Assed; Soares, Andrey; Schutz, Fabio Augusto Barros; Cronemberger, Eduardo; de Almeida Luz, Murilo; Martins, Suelen Patricia Dos Santos; Muniz, David Queiroz Borges; Carcano, Flavio Mavignier; Smaletz, Oren; Peixoto, Fabio Affonso; Gomes, Andrea Juliana; Cruz, Felipe Melo; Franke, Fabio Andre; Herchenhorn, Daniel; Gidekel, Rosemarie; Werutsky, Gustavo; Rebelatto, Taiane Francieli; Gomes de Jesus, Rafaela; Souza, Vinicius Carrera; Fay, Andre Poisl; Maluf, Fernando Cotait Share Save
TROPION-Lung07: Phase III study of Dato-DXd plus pembrolizumab ± platinum-based chemotherapy as 1L therapy for advanced non-small-cell lung cancer Okamoto, Isamu; Kuyama, Shoichi; Girard, Nicolas; Lu, Shun; Franke, Fabio; Li, Ziming; Danchaivijitr, Pongwut; Han, Ji-Youn; Sun, Jong-Mu; Sugawara, Shunichi; Pan, Edward; Ren, Natalie; Chen, Aiying; Rajagopalan, Rachana; Lisberg, Aaron E. Share Save
heredERA Breast Cancer: a phase III, randomized, open-label study evaluating the efficacy and safety of giredestrant plus the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with previously untreated HER2-positive, estrogen receptor-positive locally advanced or metastatic breast cancer Kuemmel, Sherko; Harper-Wynne, Catherine; Park, Yeon Hee; Franke, Fabio; de Laurentiis, Michelino; Schumacher-Wulf, Eva; Eiger, Daniel; Heeson, Sarah; Cardona, Andres; Ozyilkan, Ozgur; Morales-Vasquez, Flavia; Metcalfe, Ciara; Hafner, Marc; Restuccia, Eleonora; O'Shaughnessy, Joyce Share Save
TROPION-Lung07: A phase III trial of datopotamab deruxtecan (Dato-DXd) plus pembrolizumab (pembro) with or without platinum chemotherapy (Pt-CT) as first-line (1L) therapy in advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC) with PD-L1 expression Okamoto, I.; Kuyama, S.; Girard, N.; Lu, S.; Franke, F. A.; Pan, E.; Ren, N.; Chen, A.; Oputa, E.; Lisberg, A. E. Share Save
heredERA Breast Cancer: Phase III study of first-line, fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection ± giredestrant (GDC-9545) for estrogen receptor+, HER2+advanced breast cancer Kuemmel, Sherko; Harper-Wynne, Catherine; Park, Yeon H.; Franke, Fabio; De laurentiis, Michelino; Schumacher-Wulf, Eva; Eiger, Daniel; Heeson, Sarah; Shivhare, Mahesh; Restuccia, Eleonora; O'Shaughnessy, Joyce Share Save
A phase 2 study of first-line nivolumab in patients with locally advanced or metastatic cutaneous squamous-cell carcinoma Munhoz, Rodrigo R.; Nader-Marta, Guilherme; de Camargo, Veridiana P.; Queiroz, Marcello M.; Cury-Martins, Jade; Ricci, Herminia; de Mattos, Marcela R.; de Menezes, Thiago A. F.; Machado, Guilherme U. C.; Bertolli, Eduardo; Barros, Milton; de Souza, Carina E.; Franke, Fabio; Ferreira, Fabio O.; Feher, Olavo; de Castro Jr, Gilberto Share Save
Correlation between work productivity loss and EORTC QLQ-C30 and-BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2-advanced breast cancer Tripathy, Debu; Curteis, Tristan; Hurvitz, Sara; Yardley, Denise; Franke, Fabio; Babu, K. Govind; Wheatley-Price, Paul; Im, Young-Hyuck; Pencheva, Radost; Eddowes, Lucy A.; Dionne, Pierre-Alexandre; Chandiwana, David; Pathak, Purnima; Lanoue, Brad; Harbeck, Nadia Share Save
A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415) Maluf, Fernando C.; Schutz, Fabio A.; Cronemberger, Eduardo H.; Luz, Murilo de A.; Martins, Suelen P. S.; Muniz, David Q. B.; Bastos, Diogo A.; Carcano, Flavio M.; Smaletz, Oren; Soares, Andrey; Peixoto, Fabio A.; Gomes, Andrea J.; Cruz, Felipe M.; Franke, Fabio A.; Herchenhorn, Daniel; dos Santos, Telma M.; Fabricio, Vanessa de C.; Gidekel, Rosemarie; Werutsky, Gustavo; de Jesus, Rafaela G.; Souza, Vinicius C.; Fay, AndreP. Share Save
Share Save
Health-related quality of life (HRQoL) in ACIS: A phase III trial of apalutamide with abiraterone acetate and prednisone (APA plus AAP) vs AAP in metastatic castration-resistant prostate cancer (mCRPC) Oudard, S. M.; Bevans, K. B.; Attard, G.; Efstathiou, E.; Flaig, T. W.; Franke, F. A.; Goodman, O. B., Jr.; De Giorgi, U.; Pieczonka, C. M.; Yeruva, K.; De Porre, P.; Brookman-May, S. D.; Dibaj, S.; Wu, D.; Mundle, S. D.; McCarthy, S.; Steuber, T.; Suzuki, H.; Rathkopf, D. E.; Saad, F. Share Save
Overall survival (OS) results by age subgroup from the phase III MONALEESA-7 (ML-7) trial of premenopausal patients (pts) with HR+/HER2-advanced breast cancer (ABC) treated with endocrine therapy (ET) ± ribociclib (RIB) Lu, Y-S.; El Saghir, N. S.; Hurvitz, S. A.; Tripathy, D.; Cardoso, F.; Colleoni, M. A.; Campos-Gomez, S.; Franke, F. A.; Oregan, R.; Wang, C.; Wang, Y.; Zarate, J. P.; Chakravartty, A.; Im, S-A. Share Save
Updated overall survival (OS) results from the phase III MONALEESA-7 trial of pre- or perimenopausal patients with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2-) advanced breast cancer (ABC) treated with endocrine therapy (ET) ± ribociclib Tripathy, Debu; Im, Seock-Ah; Colleoni, Marco; Franke, Fabio; Bardia, Aditya; Harbeck, Nadia; Hurvitz, Sara; Chow, Louis; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Vazquez, Rafael Villanueva; Jung, Kyung Hae; Babu, K. Govind; Wheatley-Price, Paul; De laurentiis, Michelino; Im, Young-Hyuck; Kummel, Sherko; El-Saghir, Nagi; Liu, Mei-Ching; Kaur, Sharonjeet; Gasch, Claudia; Wang, Craig; Wang, Yongyu; Chakravartty, Arunava; Lu, Yen-Shen; Liu, Mei-Ching Share Save
Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors Fizazi, Karim; Drake, Charles G.; Beer, Tomasz M.; Kwon, Eugene D.; Scher, Howard, I; Gerritsen, Winald R.; Bossi, Alberto; van den Eertwegh, Alfons J. M.; Krainer, Michael; Houede, Nadine; Santos, Ricardo; Mahammedi, Hakim; Ng, Siobhan; Danielli, Riccardo; Franke, Fabio A.; Sundar, Santhanam; Agarwal, Neeraj; Bergman, Andre M.; Ciuleanu, Tudor E.; Korbenfeld, Ernesto; Sengelov, Lisa; Hansen, Steinbjorn; McHenry, M. Brent; Chen, Allen; Logothetis, Christopher Share Save
Health-related quality of life in premenopausal women with hormone-receptor-positive, HER2-negative advanced breast cancer treated with ribociclib plus endocrine therapy: results from a phase III randomized clinical trial (MONALEESA-7) Harbeck, Nadia; Franke, Fabio; Villanueva-Vazquez, Rafael; Lu, Yen-Shen; Tripathy, Debu; Chow, Louis; Babu, Govind K.; Im, Young-Hyuck; Chandiwana, David; Gaur, Anil; Lanoue, Brad; Rodriguez-Lorenc, Karen; Bardia, Aditya Share Save
Patient-reported outcomes, including work productivity, from the MONALEESA-7 trial of ribociclib plus endocrine therapy in patients with HR+/HER2-advanced breast cancer Harbeck, Nadia; Hurvitz, Sara; Bardia, Aditya; Franke, Fabio; Babu, K. Gonvind; Wheatley-Price, Paul; Im, Young-Hyuck; Altundag, Kadri; Ridolfi, Antonia; Chandiwana, David; Lanoue, Brad; Menon, Lakshmi; Tripathy, Debu Share Save
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer Im, S. -A.; Lu, Y. -S.; Bardia, A.; Harbeck, N.; Colleoni, M.; Franke, F.; Chow, L.; Sohn, J.; Lee, K. -S.; Campos-Gomez, S.; Villanueva-Vazquez, R.; Jung, K. -H.; Chakravartty, A.; Hughes, G.; Gounaris, I.; Rodriguez-Lorenc, K.; Taran, T.; Hurvitz, S.; Tripathy, D. Share Save
Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial Reck, Martin; Schenker, Michael; Lee, Ki Hyeong; Provencio, Mariano; Nishio, Makoto; Lesniewski-Kmak, Krzysztof; Sangha, Randeep; Ahmed, Samreen; Raimbourg, Judith; Feeney, Kynan; Corre, Romain; Franke, Fabio Andre; Richardet, Eduardo; Penrod, John R.; Yuan, Yong; Nathan, Faith E.; Bhagavatheeswaran, Prabhu; DeRosa, Michael; Taylor, Fiona; Lawrance, Rachael; Brahmer, Julie Share Save
Genetic landscape of premenopausal HR+/HER2-advanced breast cancer (ABC) based on comprehensive circulating tumor DNA analysis and association with clinical outcomes in the Phase III MONALEESA-7 trial Bardia, Aditya; Su, Faye; Solovieff, Nadia; Im, Seock-Ah; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Jung, Kyung Hae; Villanueva Vazquez, Rafael; Lu, Yen-Shen; Franke, Fabio; Hurvitz, Sara; Harbeck, Nadia; Chow, Louis; Lorenc, Karen Rodriguez; Taran, Tetiana; Babbar, Naveen; Tripathy, Debu Share Save
Ribociclib with a non-steroidal aromatase inhibitor and goserelin in premenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer: MONALEESA-7 age subgroup analysis Tripathy, D.; Campos-Gomez, S.; Lu, Y-S; Franke, F.; Bardia, A.; Wheatley-Price, P.; Cruz, F. M.; Hegg, R.; Cardoso, F.; Gaur, A.; Kong, O.; Diaz-Padilla, I.; Miller, M.; Hurvitz, S. Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
BMC CANCER.png)
OAAI
.png){kind=icon}
Share.png){kind=icon}
Save